tiprankstipranks
Trending News
More News >
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market
Advertisement

BioMark Diagnostics (BUX) Financial Statements

Compare
3 Followers

BioMark Diagnostics Financial Overview

BioMark Diagnostics's market cap is currently C$35.73M. The company's EPS TTM is C$; its P/E ratio is ―; BioMark Diagnostics is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in CAD

BioMark Diagnostics Earnings and Revenue History

BioMark Diagnostics Debt to Assets

BioMark Diagnostics Cash Flow

BioMark Diagnostics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis